XML 58 R14.htm IDEA: XBRL DOCUMENT
v3.19.3

Stock-based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock-based Compensation | NOTE 8 —Stock-based Compensation As of September 30, 2019, the Company had the 2012 Equity Incentive Plan (the “2012 Option Plan”), and 2019 Equity Incentive Plan (the “2019 Option Plan”) in place. As of September 30, 2019, the number of shares available to be issued under the 2012 Option Plan and 2019 Option Plan were zero and 2,011,449 respectively. The Option Plans provides for the grant of incentive and non-statutory stock options (“Options”), stock appreciation rights (“SAR”), restricted stock awards (“RSA”), and restricted stock unit awards (“RSU”) to employees, nonemployee directors, and consultants of the Company. Option awards granted under the Option Plan generally become exercisable ratably over a two-year or four-year period following the date of grant and expire ten years from the date of grant. At the discretion of the Company’s Board of Directors, certain awards may be exercisable immediately at the date of grant but are subject to a repurchase right, under which the Company may buy back any unvested shares at their original exercise price in the event of an employee’s termination prior to full vesting. All other awards are exercisable only to the extent vested. At September 30, 2019 and December 31, 2018, there were no shares that had been early exercised that were subject to the Company’s repurchase right at that date. The exercise price or strike price for Options and SARs granted under the Option Plan must generally be at least equal to 100% of the fair value of the Company’s common stock at the date of grant, as determined by the Board of Directors. The exercise price of incentive stock options granted under the Option Plan to ten percent or greater stockholders must be at least equal to 110% of the fair value of the Company’s common stock at the date of grant, as determined by the Board of Directors, and are not exercisable after five years from the date of grant. The Company’s board of directors adopted, and its stockholders approved, the 2019 Employee Stock Purchase Plan and the 2019 Equity Incentive Plan in March 2019 and April 2019, respectively, each of which became effective in connection with the IPO. There are 337,007 shares of common stock reserved for issuance under the 2019 Employee Stock Purchase Plan. Additionally, the number of shares of common stock reserved for issuance under the 2019 Employee Stock Purchase Plan will automatically increase on January 1 of each calendar year for 10 years, starting January 1, 2020, and ending on, and including, January 1, 2029, in an amount equal to the lesser of 1% of the total number of shares of capital stock outstanding on December 31st of the prior calendar year, and (ii) 500,000 shares, unless the board of directors or compensation committee determines prior to such date that there will be a lesser increase, or no increase. 1,885,039 shares of common stock are reserved for future issuance under the 2019 Equity Incentive Plan, plus the number of shares subject to outstanding stock options or other stock awards that were granted under the 2012 Option Plan that are forfeited, terminated, expire or are otherwise not issued. Additionally, the number of shares of common stock reserved for issuance under the 2019 Equity Incentive Plan will automatically increase on January 1 of each calendar year for 10 years, starting January 1, 2020 and ending on and including January 1, 2029, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31 of the prior calendar year, unless the board of directors or compensation committee determines prior to the date of increase that there will be a lesser increase, or no increase. As of September 30, 2019, no shares have been issued under the 2019 Employee Stock Purchase Plan. On April 10, 2019, the Company granted an aggregate of 128,000 restricted stock units to the Company’s executives of which 90,000 are outstanding at September 30, 2019. On May 13, 2019, the Company granted a fully vested restricted stock award of 383,197 shares, and issued 210,758 net shares of common stock after withholding 172,439 shares of common stock totaling $1,897, recorded as a reduction to additional paid-in capital, to satisfy tax obligations associated with the grant, to the Company’s Chief Executive Officer as a bonus pursuant to his employment agreement. As a result, the Company recorded $4,215 as compensation expense to operating expenses under the Statement of Operations during the nine months ended September 30, 2019. In connection with the IPO, the Company accelerated vesting of 201,666 options dated September 10, 2018, pursuant to the employment agreement of the Company’s Chief Financial Officer. As a result, the Company recorded $287 as compensation expense to operating expenses under the Statement of Operations during the nine months ended September 30, 2019. Stock-based compensation expense for the three and nine months ended September 30, 2019 and 2018 is as follows:
| Three Months Ended |  |  | Nine Months Ended |
| September 30 |  |  | September 30 |
| 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
Research and development | $ | 93 |  |  | $ | 10 |  |  | $ | 268 |  |  | $ | 21 |
Sales and marketing |  | 65 |  |  | 16 |  |  |  | 543 |  |  | 33 |
General and administrative |  | 114 |  |  | 28 |  |  |  | 5,045 |  |  | 57 |
Cost of revenues |  | 35 |  |  | 9 |  |  |  | 55 |  |  | 18 |
| $ | 307 |  |  | $ | 63 |  |  | $ | 5,911 |  |  | $ | 129 |
Stock Options: Stock option activity for the nine months ended September 30, 2019 is as follows:
|  |  |  |  |  |  |  |  |  | Weighted average |  |  |  |  |
|  |  |  |  |  | Weighted average |  |  | remaining |  |  | Aggregate |
|  |  |  |  |  | exercise price |  |  | contractual life |  |  | Intrinsic |
|  | Options |  |  | per share |  |  | (in years) |  |  | Value |
Outstanding at January 1, 2019 |  |  | 1,320,197 |  |  | $ | 0.77 |  |  |  | 7.99 |  |  | $ | 8,465 |
Options granted |  |  | 637,213 |  |  | $ | 10.94 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (85,559 | ) |  | $ | 0.81 |  |  |  |  |  |  |  |  |
Options forfeited |  |  | (150,730 | ) |  | $ | 6.64 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Outstanding at September 30, 2019 |  |  | 1,721,121 |  |  | $ | 4.02 |  |  |  | 7.93 |  |  | $ | 2,541 |
Vested and expected to vest at September 30, 2019 |  |  | 1,721,121 |  |  | $ | 4.02 |  |  |  | 7.93 |  |  | $ | 2,541 |
Vested at September 30, 2019 |  |  | 1,139,418 |  |  | $ | 2.72 |  |  |  | 7.33 |  |  | $ | 1,993 |
As of September 30, 2019, there was approximately $2,473 of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of three years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration